GSK’s US$10.6b Nuvalent Deal Highlights Lung Cancer And Valuation Upside

GSK Buys Nuvalent To Deepen Oncology Focus And Future Lung Cancer Revenue

Here Are Wednesday’s Top Wall Street Analyst Research Calls: BILL Holdings, Cava Group, Entergy, GlobalFoundries, Hess Midstream, Nike, Pfizer, SharkNinja, STMicroelectronics, and More

GSK's Nuvalent deal tackles HIV cliff to win cautious backing from analysts

Nike downgraded, Oscar Health upgraded: Wall Street's top analyst calls

Deerfield Management Announces Portfolio Company Nuvalent, Inc. to be Acquired by GSK

Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion

MarketBeat Week in Review – 06/08 - 06/12

The biotech market is rebounding. So where are the executive jobs?

Here’s What the Acquisition of Nuvalent Means for Nuvation Bio (NUVB)